Brief: Zentalis Pharmaceuticals' CFO Melissa Epperly Resigns, Board Appoints President Cam Gallagher As Interim CFO
April 11 (Reuters) - Zentalis Pharmaceuticals Inc
ZNTL.O :
* ZENTALIS PHARMACEUTICALS INC - ON APRIL 5, MELISSA
EPPERLY
RESIGNED AS CHIEF FINANCIAL OFFICER OF ZENTALIS PHARMACEUTICALS
EFFECTIVE IMMEDIATELY
* ZENTALIS PHARMACEUTICALS INC - CONDUCTING A SEARCH FOR A
NEW
CHIEF FINANCIAL OFFICER
* ZENTALIS PHARMACEUTICALS INC - BOARD APPOINTED COMPANY'S
PRESIDENT, CAM GALLAGHER, AS INTERIM CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:n0001725160-24-000087
Further company coverage: ZNTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer